Immune and inflammatory responses to leishmania amazonensis isolated from different clinical forms of human leishmaniasis in CBA mice

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 1, 2011, Pages 23-31

  de Souza, Valderes L ^a   Veras, Patrícia S T ^a   Welby Borges, Marcus ^a,b   Silva, Tânia M C ^a   Leite, Bruna R ^a   Ferraro, Rodrigo B ^c   Meyer Fernandes, José R ^c   Barral, Aldina ^a,b   Costa, Jackson Mauricio Lopes ^a   de Freitas, Luiz A R ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Enzymatic activity; Inflammatory responses; Leishmania amazonensis

Indexed keywords

LEISHMANIA AMAZONENSIS; MUS;

EID: 79851499328     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762011000100004     Document Type: Article

References (29)

1. Afonso LC, Scott P 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61: 2952-2959.
2. Alexander J, Blackwell JM 1986. The immunological significance of genetically determined cross reactivity between taxonomically distinct Leishmania species. In JA Riou (ed.), Leishmania, taxonomie et phylogenèse: application éco-épidemiologiques, Institut Méditerranéen d'Etudes Epidémiologiques et Ecologiques, Montpellier, p. 185-191.
3. Almeida RP, Barral-Netto M, De Jesus AM, De Freitas LA, Carvalho EM, Barral A 1996. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Am J Trop Med Hyg 54: 178-184.
4. Andrade ZA, Reed SG, Roters SB, Sadigursky M 1984. Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol 114: 137-148.
5. Barral A, Pedral-Sampaio D, Grimaldi Júnior G, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaro R, Barral-Netto M, Carvalho EM, Johnson WD 1991. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44: 536-546.
6. Barral-Netto M, de Freitas LA, Andrade ZA 1987. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice. Am J Pathol 127: 271-278.
7. Berrêdo-Pinho M, Peres-Sampaio CE, Chrispim PP, Belmont-Firpo R, Lemos AP, Martiny A, Vannier-Santos MA, Meyer-Fernandes JR 2001. A Mg-dependent ecto-ATPase in Leishmania amazonensis and its possible role in adenosine acquisition and virulence. Arch Biochem Biophys 391: 16-24.
8. Camargo EP, Coelho JA, Moraes G, Figueiredo EN 1978. Trypanosoma spp, Leishmania spp and Leptomonas spp: enzymes of ornithine-arginine metabolism. Exp Parasitol 46: 141-144.
9. Co DO, Hogan LH, Kim SI, Sandor M 2004. Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clin Immunol 113: 130-136.
10. Corraliza IM, Campo ML, Soler G, Modolell M 1994. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174: 231-235.
11. Ding AH, Nathan CF, Stuehr DJ 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412.
12. Gramiccia M, Gradoni L, Pozio E 1987. Leishmania infantum sensu lato as an agent of cutaneous leishmaniasis in Abruzzi region (Italy). Trans R Soc Trop Med Hyg 81: 235-237.
13. Hanna S, Gharib B, Lepidi H, Montet JC, Dumon H, de Reggi M 2005. Experimental schistosomiasis, protective aspects of granulomatous reaction in the mouse liver. Parasitol Res 96: 6-11.
14. Ilg T, Stierhof YD, McConville MJ, Overath P 1995. Purification, partial characterization and immunolocalization of a proteophosphoglycan secreted by Leishmania mexicana amastigotes. Eur J Cell Biol 66: 205-215.
15. la Sala A, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G 2003. Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 73: 339-343.
16. Lemos de Souza V, Ascenção Souza J, Correia Silva TM, Sampaio Tavares Veras P, Rodrigues de-Freitas LA 2000. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect 2: 1807-1815.
17. Lima HC, Bleyenberg JA, Titus RG 1997. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today 13: 80-82.
18. Magill AJ, Grögl M, Gasser RA Jr, Sun W, Oster CN 1993. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 328: 1383-1387.
19. Meyer-Fernandes JR, Dutra PM, Rodrigues CO, Saad-Nehme J, Lopes AH 1997. Mg-dependent ecto-ATPase activity in Leishmania tropica. Arch Biochem Biophys 341: 40-46.
20. Mizumoto N, Kumamoto T, Robson SC, Sévigny J, Matsue H, Enjyoji K, Takashima A 2002. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8: 358-365.
21. NRC - National Research Council 1996. Guide for the care and use of laboratory animals, National Academy Press, Washington, 140 pp.
22. Pinheiro CM, Martins-Duarte ES, Ferraro RB, Fonseca de Souza AL, Gomes MT, Lopes AH, Vannier-Santos MA, Santos AL, Meyer-Fernandes JR 2006. Leishmania amazonensis: biological and biochemical characterization of ecto-nucleoside triphosphate diphosphohydrolase activities. Exp Parasitol 114: 16-25.
23. Pratlong F, Bastien P, Perello R, Lami P, Dedet JP 1995. Human cutaneous leishmaniasis caused by Leishmania donovani sensu stricto in Yemen. Trans R Soc Trop Med Hyg 89: 398-399.
24. Reiner SL, Zheng S, Wang ZE, Stowring L, Locksley RM 1994. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med 179: 447-456.
25. Ridley DS, Ridley MJ 1983. The evolution of the lesion in cutaneous leishmaniasis. J Pathol 141: 83-96.
26. Schnur LF, Morsy TA, Feinsod FM, el Missiry AG 1985. Is Leishmania major the cause of infantile kala-azar in Alexandria, Egypt? Trans R Soc Trop Med Hyg 79: 134-135.
27. Titus RG, Marchand M, Boon T, Louis JA 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545-555.
28. Veras PS, de Chastellier C, Rabinovitch M 1992. Transfer of zymosan (yeast cell walls) to the parasitophorous vacuoles of macrophages infected with Leishmania amazonensis. J Exp Med 176: 639-646.
29. Wilson J, Huynh C, Kennedy KA, Ward DM, Kaplan J, Aderem A, Andrews NW 2008. Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathog 4: e1000179.